Mentoring patient-oriented researchers in pediatric diarrhea
Project Number5K24AI166087-02
Former Number1K24AI166087-01
Contact PI/Project LeaderLEUNG, DANIEL TED
Awardee OrganizationUNIVERSITY OF UTAH
Description
Abstract Text
Project Summary
Diarrheal illness is the second most common cause of non-neonatal death among young children worldwide,
and is a major cause of morbidity. Current etiologic diagnosis of diarrhea relies on microbial detection, and
decisions for antibiotics commonly empiric. However, the majority of cases of diarrhea do not benefit from
antibiotic use, and testing for all potential pathogens is neither financially nor logistically feasible. Thus,
methods to improve the clinical management of pediatric diarrheal illness, including strategies for antimicrobial
and diagnostic stewardship, are needed. Clinical prediction rules are potential tools to address this need, and
in this K24 application, our overall goal is to explore strategies to improve clinical decision-making for diarrhea
management, through use of spatial-temporal data and biomarkers. Dr. Leung, the PI, is a physician-scientist
with training in clinical infectious diseases, immunology, microbiology, and epidemiology, with a focus on
enteric infections, especially those that cause diarrheal illness in children in limited-resource settings. He has
mentored over 40 patient-oriented researchers (PORs) since the start of his independent research program in
2014; additionally, he has co-mentored numerous PORs in collaboration with scientists and clinicians working
in low- and middle-income countries. Leveraging infrastructure already in place from three ongoing NIH-funded
awards (R01AI130378, R01AI135114, R01AI135115), as well as Gates Foundation-funded studies, he
proposes to augment his current POR by addressing the following aims: 1) To examine the use of spatial-
temporal data for individual-level clinical prediction of pediatric diarrhea, where the use of A) serosurveillance,
B) molecular diagnostic, and C) earth observation-derived data will be explored, and 2) To identify clinical use-
cases, and potential candidates, of fecal biomarkers that complement clinical decision support tools for
management of pediatric diarrhea, using both qualitative methods to examine end-user perspectives and
identify use-cases, and metabolomics and transcriptomics methods to identify candidate biomarkers. To
accomplish these aims, he has established a co-mentoring team of experienced investigators with diverse
expertise in statistical methods, biomarker discovery, and mentoring of POR investigators. This award will
provide protected time for Dr. Leung to improve and increase his mentoring capacity of POR trainees, expand
his expertise and experience in bioinformatics, and generate data for future projects to improve the
management and knowledge of pediatric diarrheal infections.
Public Health Relevance Statement
Project Narrative
Diarrheal infections are a top cause of death and illness in young children worldwide. We propose to use new
epidemiological and big data methods to identify data sources, including biomarkers, that could help with the
clinical management of children with diarrhea. Through these projects, we will build the capacity of Dr. Leung
to mentor patient-oriented researchers in pediatric diarrhea.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdvanced DevelopmentAntibioticsAreaAwardBangladeshBig Data MethodsBioinformaticsBiological MarkersBiometryCause of DeathCessation of lifeChildChildhoodCholeraClinicalClinical ManagementCollaborationsCommunicable DiseasesComplementCountryDataData ScienceData SourcesDetectionDiagnosisDiagnosticDiagnostic testsDiarrheaEnrollmentEpidemiologyEtiologyFoundationsFrequenciesFundingFutureGoalsImmunologyIncomeIndividualInfectionInfrastructureKnowledgeMentorsMentorshipMethodsMicrobiologyMorbidity - disease ratePathogen detectionPhysiciansPlanet EarthPopulationProbabilityPrognosisPublic HealthQualitative MethodsResearchResearch DesignResearch PersonnelResource-limited settingRoleScientistSerologyStatistical MethodsTestingTimeTrainingTriageUnited States National Institutes of HealthUniversitiesUtahViralWorkantimicrobialbiomarker discoverybiomarker identificationcandidate identificationcandidate markercare seekingclinical careclinical decision supportclinical decision-makingclinical predictive modelclinical predictorscohortcostdiagnostic paneldiarrheal diseaseenteric infectionepidemiologic dataexperienceimprovedlow and middle-income countriesmetabolomicsmicrobialmolecular diagnosticspathogenpatient orientedpatient oriented researchpoint of carepredictive toolsprogramsremote sensingserosurveillancespatial integrationstatisticssupport toolstooltranscriptomics
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
009095365
UEI
LL8GLEVH6MG3
Project Start Date
11-May-2023
Project End Date
30-April-2028
Budget Start Date
01-May-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$171,918
Direct Costs
$159,183
Indirect Costs
$12,735
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$171,918
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K24AI166087-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K24AI166087-02
Patents
No Patents information available for 5K24AI166087-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K24AI166087-02
Clinical Studies
No Clinical Studies information available for 5K24AI166087-02
News and More
Related News Releases
No news release information available for 5K24AI166087-02
History
No Historical information available for 5K24AI166087-02
Similar Projects
No Similar Projects information available for 5K24AI166087-02